ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Orthofix Wins “Best Patient Experience Solution” Award in 2024 MedTech Breakthrough Awards Program

Orthofix Medical Inc. (NASDAQ: OFIX), a leading global spine and orthopedics company, today announced that it has been selected as winner of the “Best Patient Experience Solution” award in the 8th annual MedTech Breakthrough Awards program. MedTech Breakthrough is an independent market intelligence organization that recognizes the top companies, technologies and products in the global digital health and medical technology market.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240516795870/en/

STIM onTrack™ mobile app tracks patient compliance data from their bone growth therapy device which is prescribed after a fracture injury, lumbar or cervical fusion. (Photo: Business Wire)

STIM onTrack™ mobile app tracks patient compliance data from their bone growth therapy device which is prescribed after a fracture injury, lumbar or cervical fusion. (Photo: Business Wire)

The 2024 MedTech Breakthrough Award recognizes the breakthrough innovation of Orthofix’s STIM onTrack mobile app that tracks patient compliance data from their bone stimulation device, which is prescribed after a fracture injury, lumbar or cervical fusion.

The STIM onTrack mobile app works with the latest generation CervicalStim, SpinalStim, and PhysioStim bone growth therapy devices. These devices are approved by the FDA and provide patients with a safe and effective nonsurgical treatment to improve nonunion fractures and spinal fusion healing. By providing a hyper-targeted experience, the mobile app addresses unique patient needs related to bone healing.

Featuring daily treatment reminders and device usage calendars, patients can stay on schedule with their treatments. The mobile app also allows patients to fill out patient reported outcome measures and submit pain scores and transmit them to their physicians, allowing for remote monitoring in between appointments.

The STIM onTrack app also provides links to educational patient resources and connects patients with Orthofix’s Patient Care team to help ensure patients understand their treatment regimens.

“We are extremely honored to be recognized for the second year in a row as a winner of the Medtech Awards – this year for Best Patient Experience Solution,” said Jason Shallenberger, President of Bone Growth Therapies. “Orthofix was the first company in this space to recognize the importance of patient engagement in their own recovery by utilizing our STIM onTrack app. This allows patients to report a variety of information back to their physician such as pain scores and treatment compliance among other things.”

The mission of the MedTech Breakthrough Awards is to honor excellence and recognize the innovation, hard work and success in a range of health and medical technology categories, including Telehealth, Clinical Administration, Patient Engagement, Electronic Health Records (EHR), Virtual Care, Medical Devices, Medical Data and Privacy, and many more. This year’s program attracted thousands of nominations from over 18 different countries throughout the world.

“The STIM onTrack mobile app provides tools designed to help patients adhere to their prescriptions and improve their clinical outcomes. Patients who take an active role in their follow-up care have a better overall recovery experience and more optimal outcomes,” said Steve Johansson, managing director, MedTech Breakthrough. “By allowing patients to remotely share their data and recovery updates, Orthofix is delivering a much-needed solution that supports physician remote patient monitoring endeavors, and aids in improving overall patient experience and outcomes.”

About Orthofix

Orthofix is a leading global spine and orthopedics company with a comprehensive portfolio of biologics, innovative spinal hardware, bone growth therapies, specialized orthopedic solutions, and a leading surgical navigation system. Its products are distributed in more than 60 countries worldwide.

The Company is headquartered in Lewisville, Texas, where it conducts general business, product development, medical education and manufacturing, and has primary offices in Carlsbad, CA, with a focus on spine and biologics product innovation and surgeon education, and Verona, Italy, with an emphasis on product innovation, production, and medical education for orthopedics. Orthofix’s global R&D, commercial and manufacturing footprint also includes facilities and offices in Irvine, CA, Toronto, Canada, Sunnyvale, CA, Maidenhead, UK, Munich, Germany, Paris, France and São Paulo, Brazil.

About MedTech Breakthrough

Part of Tech Breakthrough, a leading market intelligence and recognition platform for global technology innovation and leadership, the MedTech Breakthrough Awards program is devoted to honoring excellence and innovation in medical & health technology companies, products, services and people. The MedTech Breakthrough Awards provide a platform for public recognition around the achievements of breakthrough healthcare and medical companies and products in categories that include Patient Experience & Engagement, Health & Fitness, Medical Devices, Clinical Administration, Connected Healthcare, Medical Data, Healthcare Cybersecurity and more. For more information visit MedTechBreakthrough.com.

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.